Bringing Specificity to Disease Treatment

Affibody is focused on improving the treatment of a wide range of diseases. To achieve this, the company generates the next generation molecular imaging and drug candidates based on its unique Affibody® molecules.

Affibody® molecules can be designed to bind specifically to a large number of target proteins that play an important role in the diagnosis or treatment of disease and are well suited for molecular imaging and as the same Affibody® molecule could be charged with a cytotoxic payload, it can potentially also be used for targeted therapy.

View an animation of how the Affibody® technology will enable cancer specialists to locate and treat tumors and metastases!